Endpoint surrogacy in oncological randomized controlled trials with immunotherapies: a systematic review of trial-level and arm-level meta-analyses. Read more about Endpoint surrogacy in oncological randomized controlled trials with immunotherapies: a systematic review of trial-level and arm-level meta-analyses.
Enriched biomarker-driven clinical trials. Read more about Enriched biomarker-driven clinical trials.
Modelling and estimation for optimal treatment decision with interference. Read more about Modelling and estimation for optimal treatment decision with interference.
Effect of Erlotinib Plus Bevacizumab vs Erlotinib Alone on Progression-Free Survival in Patients With Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Phase 2 Randomized Clinical Trial. Read more about Effect of Erlotinib Plus Bevacizumab vs Erlotinib Alone on Progression-Free Survival in Patients With Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Phase 2 Randomized Clinical Trial.
ON TESTING CONDITIONAL QUALITATIVE TREATMENT EFFECTS. Read more about ON TESTING CONDITIONAL QUALITATIVE TREATMENT EFFECTS.
Toxicity Related to Radiotherapy Dose and Targeting Strategy: A Pooled Analysis of Cooperative Group Trials of Combined Modality Therapy for Locally Advanced Non-Small Cell Lung Cancer. Read more about Toxicity Related to Radiotherapy Dose and Targeting Strategy: A Pooled Analysis of Cooperative Group Trials of Combined Modality Therapy for Locally Advanced Non-Small Cell Lung Cancer.
FSEM: Functional Structural Equation Models for Twin Functional Data. Read more about FSEM: Functional Structural Equation Models for Twin Functional Data.
Celecoxib With Neoadjuvant Chemotherapy for Breast Cancer Might Worsen Outcomes Differentially by COX-2 Expression and ER Status: Exploratory Analysis of the REMAGUS02 Trial. Read more about Celecoxib With Neoadjuvant Chemotherapy for Breast Cancer Might Worsen Outcomes Differentially by COX-2 Expression and ER Status: Exploratory Analysis of the REMAGUS02 Trial.
Impact of Esophageal Motion on Dosimetry and Toxicity With Thoracic Radiation Therapy. Read more about Impact of Esophageal Motion on Dosimetry and Toxicity With Thoracic Radiation Therapy.
CRM2DIM: A SAS macro for implementing the dual-agent Bayesian continual reassessment method. Read more about CRM2DIM: A SAS macro for implementing the dual-agent Bayesian continual reassessment method.
